Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Agnostic Therapy in Rare Solid Tumors
NCT06638931
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
- Locations
-
- Hospital São Carlos Fortaleza, Ceará, Brazil
- Hospital São Rafael Salvador, Estado de Bahia, Brazil
- Hospital Santa Cruz Curitiba, Paraná, Brazil
- IDOR Recife Recife, Pernambuco, Brazil
NCT04715191
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
NCT07148050
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +40 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
NCT06198296
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
NCT05564026
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Embryonal, +20 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
NCT07224568
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +22 more
- Locations
-
- Fred Hutch Cancer Center Seattle, Washington, United States
Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children
NCT06341998
- Conditions
- Endodermal Sinus Tumor, Germ Cell Tumor, Mesonephroma, +4 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
NCT06470464
- Conditions
- Disease Attributes, Endodermal Sinus Tumor, Germ Cell Tumor, +8 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT02375204
- Conditions
- Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
NCT05103631
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
NCT04377932
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States